International Standards (IS) and International Reference Preparations help to improve between-laboratory comparability of immunoassay results and can also enable better understanding of what is being measured. The good agreement between results observed for AFP and PSA markers reflects the availability of appropriately constituted International Standards for these important tumour markers. Those for hCG are also contributing to optimal design of the next generation of hCG immunoassays. Unfortunately, however, there are as yet no International Standards for CA125, CA19-9 and other mucinous markers for which between-method agreement is poor.

In this Webinar Dr. Catharine Sturgeon will consider why this is the case and what collaborative international initiatives are required to fill the gap.

Reserve your place today, to make sure you don’t miss out on the opportunity to hear from an industry expert, about the importance of standardisation to assay performance.

Key Learning Points

• Benefits of tumour marker standardisation
• Current use and reporting of tumour markers
• How to improve tumour marker standardisation

Click here for more information and to register.